NCT05934565

Brief Summary

The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF. Participants will be randomized (1:1 ratio) to receive either the Mindful Steps intervention or usual care for 12 months, with both arms receiving a Walking for Health education booklet.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P75+ for not_applicable chronic-obstructive-pulmonary-disease

Timeline
24mo left

Started Apr 2025

Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Apr 2025Jun 2028

First Submitted

Initial submission to the registry

June 22, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 7, 2023

Completed
1.8 years until next milestone

Study Start

First participant enrolled

April 28, 2025

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

May 28, 2025

Status Verified

May 1, 2025

Enrollment Period

3.2 years

First QC Date

June 22, 2023

Last Update Submit

May 22, 2025

Conditions

Keywords

Mind-Body ExerciseFitBitMindful Steps

Outcome Measures

Primary Outcomes (1)

  • Change in physical activity

    Daily step counts will be measured as an objective proxy for physical activity using FitBit pedometers (FitBit Inspire 3)

    baseline, months 3, 6, 12, and 15

Secondary Outcomes (9)

  • Change in self-efficacy

    baseline, months 3, 6, 12, and 15

  • Change in intrinsic motivation

    baseline, months 3, 6, 12, and 15

  • Qualitative inquiry

    months 6 and 12

  • Change in disease-specific quality-of-life

    baseline, months 3, 6, 12, and 15

  • Change in exercise engagement

    baseline, months 3, 6, 12, and 15

  • +4 more secondary outcomes

Study Arms (2)

Mindful Steps

EXPERIMENTAL

Multi-modal web intervention including: pedometer with individualized step-count goals, motivational and educational content, online community forum, mind-body videos (short themed clips that support walking, plus library of mind-body exercises), online group mind-body exercise classes, star incentive system; educational booklet

Behavioral: Mindful Steps

Usual Care

NO INTERVENTION

Pragmatic usual care (standard care through participant's healthcare provider including pharmacological treatment and general advice for physical activity); educational booklet

Interventions

Mindful StepsBEHAVIORAL

Integrated website, activity tracker, and mind-body training

Mindful Steps

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of COPD (defined as cigarette smoking history \> 10 pack-years, and either a ratio of FEV1 to forced vital capacity \< 0.70 or chest CT evidence of emphysema) OR clinical diagnosis of HF syndrome (with left ventricular systolic dysfunction or preserved ejection fraction and New York Heart Association Class 1-3)
  • Medical clearance from provider to participate in an exercise program
  • Have an active email account; access to a computer device (desktop, laptop, tablet, or smartphone that supports the Fitbit app).

You may not qualify if:

  • COPD or HF exacerbation in the previous month
  • Inability to ambulate
  • Inability to collect at least 7 of 14 days of baseline step counts
  • Current participation in a cardiac or pulmonary rehabilitation program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

VA Boston

Boston, Massachusetts, 02132, United States

RECRUITING

BIDMC

Boston, Massachusetts, 02215, United States

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Testing will be facilitated by study staff who are blinded to treatment assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2-arm parallel remotely delivered randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Mind-Body Research, BIDMC General Medicine Division; Associate Professor of Medicine, Harvard Medical School

Study Record Dates

First Submitted

June 22, 2023

First Posted

July 7, 2023

Study Start

April 28, 2025

Primary Completion (Estimated)

June 30, 2028

Study Completion (Estimated)

June 30, 2028

Last Updated

May 28, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations